siRNA-mediated knock-down of NOX3: therapy for hearing loss? - Wikidata - awgldk - TriplyDB

siRNA-mediated knock-down of NOX3: therapy for hearing loss?

siRNA-mediated knock-down of NOX3: therapy for hearing loss?

http://www.wikidata.org/entity/Q30355898

about

Genome-wide association study identifies nox3 as a critical gene for susceptibility to noise-induced hearing loss.A Genetic Murine Model of Endolymphatic Hydrops: The Phex Mouse.Early investigational drugs for hearing loss.Adenosine A1 Receptor Protects Against Cisplatin Ototoxicity by Suppressing the NOX3/STAT1 Inflammatory Pathway in the Cochlea.An Endothelial Hsp70-TLR4 Axis Limits Nox3 Expression and Protects Against Oxidant Injury in Lungs The role of mitochondria in age-related hearing loss.Signaling in the Auditory System: Implications in Hair Cell Regeneration and Hearing Function.An Overview of Nanoparticle Based Delivery for Treatment of Inner Ear Disorders.

P2860

Q30413835-F35986E8-B22E-4072-86E5-0EFFD37EDD0B Q30428653-4378A024-5425-4698-8806-623B75F646B4 Q33847686-3941EDE6-10F1-495D-9E53-7A52E3F02787 Q36768399-2BE4DABD-756E-45EA-982D-E2DE456A9CBC Q37040326-C957AE31-174D-4015-87C1-AB9A9A821D88 Q38160728-9668A4EF-BD77-4F8D-B93F-846AE2EA98C7 Q39015106-5A0A8A07-F397-40D5-82DF-73D845680D0C Q45887696-1514C865-EDE0-473C-A7C3-EAFC605EC64D

P2860

siRNA-mediated knock-down of NOX3: therapy for hearing loss?

http://www.wikidata.org/entity/Q30355898

description

2012 nî lūn-bûn

@nan

2012 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

siRNA-mediated knock-down of NOX3: therapy for hearing loss?

@ast

siRNA-mediated knock-down of NOX3: therapy for hearing loss?

@en

type

label

siRNA-mediated knock-down of NOX3: therapy for hearing loss?

@ast

siRNA-mediated knock-down of NOX3: therapy for hearing loss?

@en

prefLabel

siRNA-mediated knock-down of NOX3: therapy for hearing loss?

@ast

siRNA-mediated knock-down of NOX3: therapy for hearing loss?

@en

P1433

Q30355898-3A07C88F-2673-4E66-B913-3BDAA3564B4B

P1476

Q30355898-505B2D8A-BEE2-4118-B3AC-43DCD38B39E0

P2093

Q30355898-2B5DBB8B-C2E4-4186-95EA-AC2F524D5583

Q30355898-3D2059E2-5138-446F-9BED-857102A3A0C2

Q30355898-872FA6A9-401E-4040-976F-FEC9FC24F344

Q30355898-977E05FC-4608-42CF-9065-FE020DDC0E4C

Q30355898-C65EB987-51D2-4BAD-9A64-B6043665D671

P2860

Q30355898-06BEEE41-D7BD-4951-9956-2D5C8802FF3C

Q30355898-0B67ED77-AF70-4D1D-9025-439F6456449B

Q30355898-0BFA2DDC-4AE9-438B-9495-A140DD02DE0F

Q30355898-0FA6AB9F-A95D-4A9E-85F4-A27422242B77

Q30355898-121508C9-75CE-4A58-B683-ECBBFC0DEE72

Q30355898-1D9A76A1-D17C-44AD-9FF8-5DF7499E9191

Q30355898-21089F82-29C9-4CD9-8B15-D14C93DCF77F

Q30355898-25E7CCB8-58D0-48C7-A914-235E388FE7EC

Q30355898-3E02B870-A8B5-441C-BAF5-DA85BE43A02E

Q30355898-405D0FEE-30D8-4564-AA6F-9534D075AF2B

P2888

Q30355898-1995B44B-391D-4EC6-AB51-0111838E6178

P304

Q30355898-699BBF64-39B1-4201-86D7-B2932BFF970D

P31

Q30355898-28740035-7F81-4459-ABD2-D2BA07FFB865

P356

Q30355898-12EA9CC2-5DEA-40EF-99DB-98AAE2718646

P433

Q30355898-B3953775-89B8-4EE6-906D-5DC6979EDA90

P478

Q30355898-4FB88BF3-E0C6-4067-84D4-F10D1D6CED40

P577

Q30355898-5738BB2C-E19B-4329-A92E-BD3F4F7703A5

P698

Q30355898-940BA7EA-456D-4AA5-BA95-88B92B5A3397

P932

Q30355898-C7E24D0E-5919-48C9-AD01-16847FB4A9DB

P356

S00018-012-1016-3

P1433

Cellular and Molecular Life Sciences

P1476

siRNA-mediated knock-down of NOX3: therapy for hearing loss?

@en

P2093

Debashree Mukherjea

http://www.w3.org/2001/XMLSchema#string

Leonard P Rybak

http://www.w3.org/2001/XMLSchema#string

Sarvesh Jajoo

http://www.w3.org/2001/XMLSchema#string

Tejbeer Kaur

http://www.w3.org/2001/XMLSchema#string

Vickram Ramkumar

http://www.w3.org/2001/XMLSchema#string

P2860

Cisplatin ototoxicity and protection: clinical and experimental studies

Paraquat: model for oxidant-initiated toxicity

Vestibular defects in head-tilt mice result from mutations in Nox3, encoding an NADPH oxidase

NOX3, a superoxide-generating NADPH oxidase of the inner ear

The role of oxidative stress in noise-induced hearing loss

NOX3 NADPH oxidase couples transient receptor potential vanilloid 1 to signal transducer and activator of transcription 1-mediated inflammation and hearing loss

Analysis of risk factors for cisplatin-induced ototoxicity in patients with testicular cancer.

Short interfering RNA against transient receptor potential vanilloid 1 attenuates cisplatin-induced hearing loss in the rat.

Damage and threshold shift resulting from cochlear exposure to paraquat-generated superoxide

Cisplatin ototoxicity: involvement of iron and enhanced formation of superoxide anion radicals.

P2888

s00018-012-1016-3

P304

2429-2434

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00018-012-1016-3

http://www.w3.org/2001/XMLSchema#string

P433

14

http://www.w3.org/2001/XMLSchema#string

P478

69

http://www.w3.org/2001/XMLSchema#string

P577

2012-05-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22562580

http://www.w3.org/2001/XMLSchema#string

P932

5441545

http://www.w3.org/2001/XMLSchema#string